Search

Your search keyword '"Gotua, Maia"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Gotua, Maia" Remove constraint Author: "Gotua, Maia"
99 results on '"Gotua, Maia"'

Search Results

1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus

2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

3. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study

4. Barzolvolimab Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial

5. Toward personalization of asthma treatment according to trigger factors

6. Addressing adverse synergies between chemical and biological pollutants at schools—The 'SynAir‐G' hypothesis.

7. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

8. How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19

9. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

10. Milk Allergen Micro-Array (MAMA) for Refined Detection of Cow’s-Milk-Specific IgE Sensitization

12. Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria.

16. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

17. Rhinitis associated with asthma is distinct from rhinitis alone: TARIA‐MeDALL hypothesis

18. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

19. Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities

20. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

23. Adrenaline autoinjector is under-prescribed in typical cold urticaria patients living in tropical climate countries

24. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions : A GA(2)LEN position paper

25. Adrenaline autoinjector is underprescribed in typical cold urticaria patients

26. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD‐CE study

27. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

28. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

29. Management of anaphylaxis due to COVID‐19 vaccines in the elderly

30. Digital transformation of health and care in airway diseases from research to practice

31. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

32. Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus

33. COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

34. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

35. Definition, aims, and implementation of GA²LEN/HAEi Angioedema Centers of Reference and Excellence

36. Definition, aims, and implementation of GA(2)LEN/HAEi Angioedema Centers of Reference and Excellence

38. The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria

39. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

40. ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)

41. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

42. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases: Review

43. MOESM1 of Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

44. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

46. Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA‐compliant systematic review—An EAACI position paper.

47. 6th International Symposium on Molecular Allergology (ISMA)

48. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

49. Atopic sensitization and the international variation of asthma symptom prevalence in children

50. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study

Catalog

Books, media, physical & digital resources